Literature DB >> 26122829

Shedding New Light on the Use of Imaging Technology for Glioblastoma Tumor Resection.

John Nemunaitis1, Neil Senzer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26122829      PMCID： PMC4817781          DOI： 10.1038/mt.2015.98

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  9 in total

1.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

2.  Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.

Authors:  Shuya Yano; Shinji Miwa; Hiroyuki Kishimoto; Makoto Toneri; Yukihiko Hiroshima; Mako Yamamoto; Michael Bouvet; Yasuo Urata; Hiroshi Tazawa; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

3.  Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience.

Authors:  Ricardo Díez Valle; Sonia Tejada Solis; Miguel Angel Idoate Gastearena; Reyes García de Eulate; Pablo Domínguez Echávarri; Javier Aristu Mendiroz
Journal:  J Neurooncol       Date:  2010-07-06       Impact factor: 4.130

4.  A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors.

Authors:  John Nemunaitis; Alex W Tong; Michael Nemunaitis; Neil Senzer; Anagha P Phadke; Cynthia Bedell; Ned Adams; Yu-An Zhang; Phillip B Maples; Salina Chen; Beena Pappen; James Burke; Daiju Ichimaru; Yasuo Urata; Toshiyoshi Fujiwara
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

5.  In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation.

Authors:  Hiroyuki Kishimoto; Ming Zhao; Katsuhiro Hayashi; Yasuo Urata; Noriaki Tanaka; Toshiyoshi Fujiwara; Sheldon Penman; Robert M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

6.  Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).

Authors:  R Díez Valle; J Slof; J Galván; C Arza; C Romariz; C Vidal
Journal:  Neurologia       Date:  2013-07-17       Impact factor: 3.109

7.  Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.

Authors:  Daniela Lötsch; Bahil Ghanim; Magdalena Laaber; Gabriele Wurm; Serge Weis; Stefan Lenz; Gerald Webersinke; Josef Pichler; Walter Berger; Sabine Spiegl-Kreinecker
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

8.  Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.

Authors:  E Radaelli; R Ceruti; V Patton; M Russo; A Degrassi; V Croci; F Caprera; G Stortini; E Scanziani; E Pesenti; R Alzani
Journal:  Histol Histopathol       Date:  2009-07       Impact factor: 2.303

9.  Improving the extent of malignant glioma resection by dual intraoperative visualization approach.

Authors:  Ilker Y Eyüpoglu; Nirjhar Hore; Nic E Savaskan; Peter Grummich; Karl Roessler; Michael Buchfelder; Oliver Ganslandt
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240
  9 in total
  1 in total

1.  Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.

Authors:  Yukihiko Hiroshima; Thinzar M Lwin; Takashi Murakami; Ali A Mawy; Tanaka Kuniya; Takashi Chishima; Itaru Endo; Bryan M Clary; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2016-10-03       Impact factor: 3.454
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.